Sort by
Refine Your Search
-
real-time during behavioural tasks Integrating virtual reality paradigms with behaviour and imaging to assess decision-making processes Exploring potential therapeutic interventions for NMDA receptor
-
, computer science, medicine, pharmacology, and physics. ISAS is a member of the Leibniz Association and is publicly funded by the Federal Republic of Germany and its federal states. At our location in
-
qualified women to apply for the position. Your tasks #designing, planning and performing laboratory (wind-wave facility) experiments, using state-of-the-art imaging techniques #developing computational codes
-
/or spatial multiomics, advanced imaging, iPS cells, machine learning, and computational biology. The ideal candidate will have a passion for addressing fundamental questions in biology and an eagerness
-
publications Participate in a doctoral qualification program well suited to the research focus of the CRC Your qualifications Master’s Degree in Biomedical Sciences, Animal Biology, Neuroscience, Audiology
-
TUD Dresden University of Technology, as a University of Excellence, is one of the leading and most dynamic research institutions in the country. Founded in 1828, today it is a globally oriented
-
such as biology, chemistry, pharmacology, physics, and computer science. ISAS is a member of the Leibniz Association and is publicly funded by the Federal Republic of Germany and its federal states. At our
-
PhD Student (f/m/d) for RTG Supracolloidal Structures - from Materials to Optical and Electronic ...
, pharmacy, immunology, medicine and IT develop innovative radiopharmaceuticals and novel tools for functional characterization, improved imaging and personalized treatment of tumors. The Department of Life
-
strategies for lung diseases. Our Offer The position is available as soon as possible. We offer thorough training in: Performing a wide spectrum of molecular, cell biology-related and computational
-
Bioinformatic PhD Student in Translational Immunology Reference number: 2025-0033 Cancer is constantly evolving, and so is the way we treat it. The advent of high-throughput single-cell sequencing means we can